微信公众号

官网二维码
中国癌症防治杂志

中国癌症防治杂志 ›› 2011, Vol. 3 ›› Issue (3): 235-237.doi: 10.3969/j.issn.1674-5671.2011.03.15

• 临床研究 • 上一篇    下一篇

转移性肝癌的血供对肝动脉化疗栓塞术疗效评价

沈飞, 茅力平, 孙雅君   

  1. 江苏南通市老年康复医院肿瘤科
  • 出版日期:2011-09-25 发布日期:2011-10-17

Impact of blood supply on treating metastatic liver cancer with transcatheter arterial chemoembolization

SHEN Fei, MAO Li-Ping, SUN Ya-Jun   

  • Online:2011-09-25 Published:2011-10-17

PDF (PC)

536

赞

被引次数

3

摘要： 目的 探讨转移性肝癌的血供对肝动脉化疗栓塞术（TACE）的疗效。方法 观察TACE治疗34例转移性肝癌的近期疗效和转移后生存率。结果 转移性肝癌以乏血供为主，富血供组有效率为66.7%（8/12），乏血供组为31.8%（7/22），两组疗效差异有统计学意义（P＜0.05）。富血供组6、12月转移后生存率分别为100%、75.0%，转移后中位生存期21.6月；乏血供组6、12月转移后生存率分别为81.8%、40.9%，转移后中位生存期13.5月，两组转移后中位生存期差异有统计学意义（P＜0.05）。结论 富血供的转移性肝癌治疗效果明显优于乏血供组。

关键词: 转移性肝癌, 介入, 化疗栓塞

Abstract: Objective To investigate the impact of blood supply on treating metastatic liver cancer with transcatheter arterial chemoembolization (TACE).Methods Clinical efficacy and survival rate were analyzed on 34 cases of metastatic liver cancer that were treated by TACE.Results Metastatic liver cancer was lack of blood supply-based.The values of CR+PR in hypervascular group and lack of blood supply group were 66.7% (8/12) and 31.8% (7/22) respectively，and the difference between the two groups was statistically significant (P＜0.05).The survival rates of 6-and 12-month after metastasis in hypervascular group were 100% and 75.0% respectively，while in lack of blood supply group were 81.8% and 40.9% respectively.The median survival periods after metastasis in hypervascular group and lack of blood supply group were 21.6 and 13.5 months respectively，and the difference between the two groups was statistically significant (P＜0.05).Conclusion TACE is significantly more effective for treating metastatic liver cancer with rich blood supply.

Key words: Metastatic liver cancer, Intervention, Chemoembolization